Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
Global Immuno-Oncology Market with Focus on
Assays: Size, Trends and Forecasts (2019-2023)
September 2019
Global Immuno-Oncology Market with Focus on Assays: Coverage
Executive Summary and Scope
Introduction/Market Overview
Global Market Analysis
Regional Market Analysis
Dynamics
Competitive Landscape
Company Profiling
Global Immuno-Oncology Market with Focus on Assays: Coverage
Attributes Details
Title Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)
Coverage Global and Regional
Regional Coverage North America, APAC, Europe
Market Influencing Variables Growth Drivers, Challenges, Market Trends
Forecast Period of Market 2019-2023
Competition in the Market Dominated
Key Players Merck and Co., Pfizer Inc., Amgen, F. Hoffmann-La Roche
Scope of the Report
Global Immuno-Oncology Market with Focus on Assays
Immuno-oncology, also called as cancer immunotherapy work with the help of the organs of the immune system detecting the cancer cellsas foreign bodies and thereby helping to fight against cancer. Immunotherapies help to cure lung cancer, prostate cancer, breast cancer,colorectal cancer, melanoma, head and neck cancer and various other types. There are certain benefits and risks involved in treating thecancer with the help of immunotherapies, so care must be taken while using immunotherapy along with the conventional therapies in thetreatment.
Immuno-Oncology deals with the immune system that works by recognizing the cancer cells while immuno-oncology assays are used tostudy about a drug reaction in a tumor microenvironment.
Immuno-Oncology assays are the next generation sequencing application which helps in maintaining the cell health and the cell forms byensuring the continuous analysis. The cell based immuno-oncology assays can be segmented into T Cell Assays, Natural Killer Cell Assays,Tumor Killing Assays and Tumor Cell Assays.
The global immuno-oncology market has increased at a significant growth during the year 2018 and projections are made that the marketwould rise in the next four years at a significant CAGR i.e. 2019-2023 tremendously. The immuno-oncology market with focus on assays isexpected to increase due to the rising number of cancer cases, unhealthy changes in dietary patterns, higher investments in the research anddevelopment, growing approvals of medicines for the treatment of various types of cancer, etc. Yet the market faces some challenges suchas high cost of immunotherapies, side-effects post immunotherapy and the declining composite success rate of oncology clinical trials, etc.
The global immuno-oncology market also follow some market trends which includes the accelerating immuno-oncology research,evolution of biosimilars in oncology, purchasing and reimbursement actions globally, etc.
Executive Summary
Global Immuno-Oncology Market with Focus on Assays
Market Overview
Global Immuno-Oncology Market
Global Immuno-Oncology Assays
Market
Immuno-Oncology Market with Focus on Assays: Global Analysis
Global Immuno-Oncology Market by Value
The immuno-oncology market value was US$...billion in 2018. The market is anticipated to grow in future and reach at US$...billion in 2023 increase from US$... billion in 2019. The immuno-oncology market is estimated to grow at a CAGR of …% during 2019 to 2023 years.
CAGR
2019-2023 xx%
2018 2019 2020 2021 2022 2023
US
$ B
illio
n
Immuno-Oncology Market with Focus on Assays: Global Analysis
North America, xx%
ROW, xx%
Global Immuno-Oncology Market by Region; 2018
Immuno-Oncology Market with Focus on Assays: Regional Analysis
North America Immuno-Oncology Assays Market by Value
Europe Immuno-Oncology Assays Market by Value
APAC Immuno-Oncology Assays Market by Value Region CAGR
2019-2023
North America xx%
Europe xx%
APAC xx%
2018 2019 2020 2021 2022 2023
US
$ B
illio
n
2018 2019 2020 2021 2022 2023
US
$ B
illio
n2018 2019 2020 2021 2022 2023
US
$ B
illio
n
Immuno-Oncology Market with Focus on Assays: Dynamics
Growth Driver
•Increase in Oncology Spending
•Rising Cancer Cases
Challenges
•Side Effects After Immunotherapy
•High Cost Involved
Market Trends
•Evolution of Biosimilars in Oncology
•Accelerating Immuno-Oncology Research
Immuno-Oncology Market with Focus on Assays: Competitive Landscape
• Merck and Co.
• Pfizer Inc.
• Amgen
• F. Hoffmann-La Roche
Players Profiled
Note: The graphs on this slide are only for sample representation.